Larvol Delta - The-Safety-and-Efficacy-of-Universal-CART-Cells-Targeting-BCMA-in-the-Treatment-of-Refractory-NMOSD

BRL-302 - BRL Medicine

http://clinicaltrials.gov/ct2/show/NCT06633042

Oct 9, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next